CXCR3 and COVID-19: Previous studies of SARS-CoV-2-infected patients, additionally, showed that CXCR3+ CCR6− Tfh1 cells correlated positively with titers of neutralizing antibody indicating a role of these cells in antibody maintenance and viral clearance in COVID-19 (56, 57).